MarketResearch.com logo

Recent Multiple Sclerosis (MS) Research for October 2017


Global Multiple Sclerosis Partnering 2010 to 2017
Topics: Multiple Sclerosis (MS)
Regions: Global
Global Multiple Sclerosis Drugs Market Report and Forecast to 2021
Topics: Multiple Sclerosis (MS)
Regions: Global
Global Multiple Sclerosis Drugs Market Size and Forecast to 2021
Topics: Multiple Sclerosis (MS)
Regions: Global
Europe Multiple Sclerosis Market and Competitive Landscape – 2017
Topics: Multiple Sclerosis (MS)
Regions: Europe
Multiple Sclerosis [2016]: Bulletin #3
Topics: Multiple Sclerosis (MS)
Global Cytokine Market – Growth, Trends and Forecasts (2017 - 2022)
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Central Nervous System (CNS) Therapeutic Market Analysis By Disease Type (Neurovascular Diseases, Trauma, Mental Health, Degenerative Disorder [Alzheimer’s Diseases, Parkinson’s Diseases, Multiple Sclerosis], Infections, Cancer), And Segment Forecasts, 20
Topics: Alzheimer's Disease, Cancer Treatment, Mental Health, Multiple Sclerosis (MS), CNS/Neurology, Oncology/Hematology
Global Multiple Sclerosis Market and Competitive Landscape – 2017
Topics: Multiple Sclerosis (MS)
Regions: Global
Multiple Sclerosis Pipeline Highlights – 2017 Update
Topics: Multiple Sclerosis (MS), Manufacturing, Packaging & Detailing, Drug Discovery
Market Access Impact (EU5) [MS]
Topics: Multiple Sclerosis (MS)
Regions: France, Germany
Medical Affairs Reputations (US) [MS]
Topics: Multiple Sclerosis (MS)
Regions: United States
Multiple Sclerosis - Pipeline Review, H1 2017
Topics: Multiple Sclerosis (MS), Drug Discovery
Market Access Impact (US) [MS]
Topics: Multiple Sclerosis (MS)
Regions: United States
Payer Insights: MS [2016]: Bulletin #3
Topics: Multiple Sclerosis (MS)
Real World Data -- Meeting payer needs
Topics: Multiple Sclerosis (MS)
Regions: Global
Medical Affairs Reputations (EU5) [MS]
Topics: Multiple Sclerosis (MS)
China Interferon Industry Report, 2016-2021
Topics: Research & Development, Hepatitis, Multiple Sclerosis (MS)
Regions: China
Overcoming Market Access Barriers to High Value Drugs
Topics: AIDS, HIV & STDs, Multiple Sclerosis (MS), Prescription Drugs
Global Multiple Sclerosis (MS) Therapeutics Market Research Report 2017
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
Multiple Sclerosis - Payer Insight: Update Bulletin [April 2017]
Topics: Multiple Sclerosis (MS)
Progressive Relapsing Multiple Sclerosis (PRMS) - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Market Access Impact: Multiple Sclerosis (EU5)
Topics: Multiple Sclerosis (MS)
Market Access Impact: Multiple Sclerosis (US)
Topics: Multiple Sclerosis (MS)
Regions: United States
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Drug Discovery
Multiple Sclerosis: Update Bulletin [March 2016]
Topics: Multiple Sclerosis (MS)
Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insights, 2016
Topics: Multiple Sclerosis (MS)
Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2016
Topics: Multiple Sclerosis (MS)
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Drug Discovery
Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Medical Affiars Reputation: Multiple Sclerosis (EU5)
Topics: Multiple Sclerosis (MS)
The National Multiple Sclerosis Society – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Topics: General Company Reports, Multiple Sclerosis (MS)
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2015
Topics: Multiple Sclerosis (MS), Drug Discovery
Multiple Sclerosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Topics: Multiple Sclerosis (MS), Prescription Drugs
Regions: Global
Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
NPS+ Multiple Sclerosis (US)
Topics: Multiple Sclerosis (MS)
Regions: United States
Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2016
Topics: Multiple Sclerosis (MS)
Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights, 2016
Topics: Multiple Sclerosis (MS)
Medical Affiars Reputation: Multiple Sclerosis (US)
Topics: Multiple Sclerosis (MS)
Regions: United States
Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Topics: Multiple Sclerosis (MS)
Regions: Global
Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Topics: Multiple Sclerosis (MS)
Regions: Global
NPS+ Multiple Sclerosis (EU5)
Topics: Multiple Sclerosis (MS)
Multiple Sclerosis Drugs Market and R&D Outlook 2016-2026
Topics: Multiple Sclerosis (MS)
Multiple Sclerosis: Payer Insight
Topics: Multiple Sclerosis (MS)
Neurorehabilitation Devices Market By Products (Neurorobotics, Brain-Computer Interface, Wearable Devices, Noninvasive Stimulators), By Therapy Area (Stroke, Multiple Sclerosis, Parkinson’s Disease, Cerebral Palsy, Others - Brain And Spinal Cord Injury),
Topics: Parkinson's Disease, Multiple Sclerosis (MS), Neurology Devices
Multiple Sclerosis Global Clinical Trials Review, H2, 2016
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2015
Topics: Multiple Sclerosis (MS), Drug Discovery
Secondary Progressive Multiple Sclerosis (SPMS) Global Clinical Trials Review, H2, 2015
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
U.S. Therapeutic Plasma Exchange Market by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Guillain Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - Forecasts to 202
Topics: Instrumentation & Equipment, Autoimmune, Multiple Sclerosis (MS), CNS/Neurology
Regions: United States
Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2016
Topics: Multiple Sclerosis (MS), Drug Discovery


Prev  | 1  | 2  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.